As the Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO), Dr. Solit has been at the forefront of developing breakthroughs like MSK-IMPACT®, a pioneering targeted tumor-sequencing test that helps doctors match patients with the most effective treatments.
Join us September 29
Leaders Circle Conversation
In this special session, you’ll hear physician-scientist David Solit, MD, share how Cycle for Survival has supported groundbreaking advances in targeted DNA sequencing at MSK, plus explain the ways that your support is ushering in a new era of personalized cancer medicine.
Featured speaker
David Solit, MD
Dr. Solit is the Geoffrey Beene Chair and Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at MSK.
What to expect
biotech
healing
The goal of the CMO is to expedite and streamline cancer genomics research to guide cancer treatment. The Leaders Circle plays a key role in accelerating genomic innovation at MSK, bringing more personalized treatment to patients than ever before.
volunteer_activism
For example, MSK-IMPACT wouldn’t exist without the Cycle for Survival community, which gave more than $25 million to support precision oncology at MSK and fuel the development of MSK-IMPACT from its beginning, long before it became the standard of cancer care.
directions_bike
This is a unique opportunity to learn more about your impact from one of MSK’s leading physician-scientists — who also happens to be a longtime Cycle for Survival participant. Dr. Solit has been riding on Team HOPP with his colleagues from the Human Oncology and Pathogenesis Program since 2012.